EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, and Biological Evaluation of Novel Hybrids Containing Dihydrochalcone as Tyrosinase Inhibitors to Treat Skin Hyperpigmentation

Songtao Xue, Zhiwei Li, Xiaotong Ze, Xiuyuan Wu, Chen He, Wen Shuai, Maria Marlow iD, Jian Chen, David Scurr iD, Zheying Zhu, Jinyi Xu iD, Shengtao Xu iD

Journal of Medicinal Chemistry · 13.04.2023 · 66 (7) · 5099-5117

DOI: 10.1021/acs.jmedchem.3c00012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 20.03.2023. Verfasst von Songtao Xue und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, P. R. China. Hauptthemen laut MEDLINE: Melanins, Hyperpigmentation. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: China Pharmaceutical University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelaninsHyperpigmentationAnimalsGuinea PigsMonophenol MonooxygenaseEnzyme InhibitorsChalconesCarbon Radioisotopes

Substanzen

MelaninsMonophenol MonooxygenaseEnzyme InhibitorsdihydrochalconeChalconesCarbon-11Carbon Radioisotopes

Autor:innen und Institutionen

  • School of Pharmacy, China Pharmaceutical University, 639 Longmian Avenue, Nanjing 211198, P. R. China.
  • School of Pharmacy, The University of Nottingham, University Park Campus, Nottingham NG7 2RD, UK.
  • Department of Hepatobiliary Surgery, The First People's Hospital of Kunshan, Suzhou 215300, P. R. China.

ORCID-Profile: Maria Marlow, David Scurr, Jinyi Xu, Shengtao Xu

Förderung

  • China Pharmaceutical University
  • National Natural Science Foundation of China

Zitieren

APA

Xue, S., Li, Z., Ze, X., Wu, X., He, C., Shuai, W., Marlow, M., Chen, J., Scurr, D., Zhu, Z., Xu, J., & Xu, S. (2023). Design, Synthesis, and Biological Evaluation of Novel Hybrids Containing Dihydrochalcone as Tyrosinase Inhibitors to Treat Skin Hyperpigmentation. Journal of Medicinal Chemistry, 66(7), 5099-5117. https://doi.org/10.1021/acs.jmedchem.3c00012

Vancouver

Xue S, Li Z, Ze X, Wu X, He C, Shuai W, et al. Design, Synthesis, and Biological Evaluation of Novel Hybrids Containing Dihydrochalcone as Tyrosinase Inhibitors to Treat Skin Hyperpigmentation. Journal of Medicinal Chemistry. 2023;66(7):5099-5117. doi:10.1021/acs.jmedchem.3c00012

BibTeX
@article{Xue2023,
  author = {Xue, Songtao and Li, Zhiwei and Ze, Xiaotong and Wu, Xiuyuan and He, Chen and Shuai, Wen and Marlow, Maria and Chen, Jian and Scurr, David and Zhu, Zheying and Xu, Jinyi and Xu, Shengtao},
  title = {Design, Synthesis, and Biological Evaluation of Novel Hybrids Containing Dihydrochalcone as Tyrosinase Inhibitors to Treat Skin Hyperpigmentation},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  volume = {66},
  number = {7},
  pages = {5099--5117},
  doi = {10.1021/acs.jmedchem.3c00012}
}
Kostenlos starten →